ZAMBONI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 2.818
AS - Asia 1.458
EU - Europa 1.390
SA - Sud America 206
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 28
OC - Oceania 5
Totale 5.972
Nazione #
US - Stati Uniti d'America 2.745
SG - Singapore 531
PL - Polonia 478
CN - Cina 363
DE - Germania 196
BR - Brasile 172
UA - Ucraina 155
VN - Vietnam 138
HK - Hong Kong 124
IT - Italia 104
FI - Finlandia 100
BD - Bangladesh 97
GB - Regno Unito 79
RU - Federazione Russa 66
FR - Francia 65
TR - Turchia 60
IN - India 47
IE - Irlanda 41
CA - Canada 39
SE - Svezia 24
ID - Indonesia 22
BE - Belgio 20
IQ - Iraq 19
ES - Italia 15
MX - Messico 15
JP - Giappone 13
NL - Olanda 10
AT - Austria 9
ZA - Sudafrica 9
AR - Argentina 8
AE - Emirati Arabi Uniti 7
EC - Ecuador 7
VE - Venezuela 7
IR - Iran 6
AU - Australia 5
CO - Colombia 5
CZ - Repubblica Ceca 5
LT - Lituania 5
PK - Pakistan 5
BO - Bolivia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
BB - Barbados 2
CL - Cile 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
PH - Filippine 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TM - Turkmenistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
Totale 5.906
Città #
Warsaw 477
Ashburn 378
Fairfield 269
Singapore 254
San Jose 161
Beijing 129
Hong Kong 124
Woodbridge 124
Jacksonville 122
Seattle 112
Cambridge 99
Houston 96
The Dalles 91
New York 89
Wilmington 89
Ann Arbor 83
Helsinki 75
Princeton 75
Chandler 74
Los Angeles 71
Munich 61
Dong Ket 50
Istanbul 43
Dublin 41
Council Bluffs 38
Lauterbourg 36
Ho Chi Minh City 33
Shanghai 26
Santa Clara 25
Boardman 24
Turku 23
Washington 23
Dallas 22
São Paulo 22
Hanoi 21
Brussels 20
Des Moines 20
Moscow 18
San Francisco 18
Jakarta 17
Redondo Beach 16
Chicago 15
Buffalo 14
London 14
Milan 14
Montreal 14
Nanjing 14
Atlanta 13
San Diego 13
Falkenstein 12
San Mateo 12
Denver 11
Kocaeli 11
Tokyo 11
Augusta 10
Baghdad 10
Bari 10
Shenyang 10
Columbus 9
Manchester 9
Mexico City 9
Nuremberg 9
Orem 9
Phoenix 9
Rome 9
Toronto 9
Boston 8
Chennai 8
Dearborn 8
Düsseldorf 8
Jinan 8
Monmouth Junction 8
Stockholm 8
Tianjin 8
Da Nang 7
Frankfurt am Main 7
Johannesburg 7
Nürnberg 7
Porto Alegre 7
Vienna 7
Ardabil 6
Brescia 6
Nanchang 6
Rio de Janeiro 6
Brooklyn 5
Changsha 5
Haikou 5
Hebei 5
Honolulu 5
Leawood 5
Tampa 5
Vancouver 5
Ankara 4
Charlotte 4
City of London 4
Guangzhou 4
Guayaquil 4
Jiaxing 4
Mumbai 4
New Delhi 4
Totale 4.071
Nome #
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 251
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 250
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration 236
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 229
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy 218
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection 208
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 194
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 183
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 172
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 170
Prediction tools in non-muscle invasive bladder cancer 167
Histological variants in non-muscle invasive bladder cancer 158
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 156
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 144
IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY 141
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration 135
MANAGEMENT AND PROGNOSIS OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY: RETROSPECTIVE ANALYSIS OF A CONTEMPORARY COHORT 133
OUTCOMES OF A PHASE II I RANDOMIZED CONTROLLED TRIAL COMPARING PREVENTIVE VERSUS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY 133
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes 131
The effect of perioperative blood transfusion on oncological outcomes in radical cystectomy patients: a narrative review 128
Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy 126
ROBOT-ASSISTED PARTIAL NEPHRECTOMYAND BILATERAL PYELOLYTHOTOMY OF ECTOPIC PELVIC KIDNEYS 125
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 122
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis 122
A thigh urinary fistula following radical prostatectomy and external beam radiation therapy for prostate cancer: a case report 119
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 114
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit 114
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 113
Single postoperative instillation for non-muscle invasive bladder cancer: Are there still any indication? 110
CLINICAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER, DEFINING OPTIMAL SURVEILLANCE AFTER SURGERY 108
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 104
INCIDENCE AND IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN CANDIDATES FOR RADICAL CYSTECTOMY: RESULTS FROM A MULTICENTER COLLABORATION 103
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 103
THE IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN IN UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS TREATED WITH NEPHROURETERECTOMY: A MULTICENTER COLLABORATION 95
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 87
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide 85
COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMYIN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION 82
Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer 81
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial 81
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 80
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 80
THE IMPACT OF TREATMENT MODALITY ON SURVIVAL IN PATIENTS WITH CLINICAL NODE POSITIVE BLADDER CANCER 75
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival 69
Precision medicine in localized bladder cancer: Personalizing therapies to improve outcomes 65
THE NECESSITY OF A SECOND TRANSURETHRAL RESECTION FOR PATIENTS DIAGNOSED WITH PTAHG TUMOR AT FIRST TUR: A MULTICENTER COLLABORATION OF EAU YOUNG ACADEMIC UROLOGISTS UROTHELIAL CARCINOMA GROUP 59
null 13
Totale 5.972
Categoria #
all - tutte 29.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022296 0 57 5 13 11 23 5 26 16 33 22 85
2022/2023264 40 5 7 19 20 62 2 28 45 0 24 12
2023/2024489 22 6 34 54 29 133 7 40 67 12 5 80
2024/2025869 10 5 3 123 76 72 84 43 122 56 160 115
2025/20261.976 186 189 109 280 245 169 277 64 92 149 146 70
2026/202783 46 37 0 0 0 0 0 0 0 0 0 0
Totale 5.972